Weleda at a Glance
• 2010Sales: CHF 385.3 million
• Personnel: 1931 (full time) at the end of 2010
•Key Personnel: Patrick Sirdey, chief executive officer; Moritz Aebersold, director BU international markets; Peter Braun, director BU pharma; Patrick Kersting, chief financial officer; Andreas Sommer, director BU natural and organic cosmetics. Weleda Board of Directors—Georg Fankhauser, chairman; Barbara Schneider, deputy chairman and member of the audit committee; Rolf Kerler, member of the audit committee; Dr. Giancarlo Buccheri, Prof. Götz Werner, Paola Ghillani.
•Major Products: Personal care products including facial and body skin care, baby care, oral and hair care products, as well as topical and ingestible pharmaceutical products.
By category, 72% of Weleda’s revenues stem from its natural and organic personal care products which include items like its best selling diaper changing cream plus a full range of facial and body skin care, hair care products and oral care. The remainder comes from its pharmaceuticals business, which includes a range of topical and ingestible treatments and products for a variety of conditions ranging from hay fever to upset stomach to common aches and pains.
Pomegranate is one of the natural ingredients featured in Weleda's skin care line.
The price the farmers receive is considerably higher than the market standard, according to Weleda, and even exceeds the current fair trade recommendations. In return for this price, the farmers commit to producing organic sesame with an organic purity of 97%.